{
  "Variants Include": [
    {
      "Gene": "a - synuclein",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease and dementia with Lewy bodies",
    "MONDO": "MONDO:0005296, MONDO:0005298"
  },
  "Experiment Method": [
    {
      "Assay Method": "Expression and purification of recombinant human a - synucleins",
      "Material used": {
        "Material Source": "Bacteria",
        "Material Name": "BL21(DE3)",
        "Description": "Expression clones were transformed into BL21(DE3) and expression induced using 0.2% L - Arabinoside."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Preparation of fluorescence - labeled liposomes",
      "Material used": {
        "Material Source": "Commercial products",
        "Material Name": "Brain phosphatidylcholine, cholesterol, brain phosphatidylserine, 3,3’ - Dioctadecyloxacarbocyanine perchlorate",
        "Description": "Brain phosphatidylcholine (PC) and cholesterol were purchased from Avanti Polar Lipids. Brain phosphatidylserine (PS) was obtained from Sigma - Aldrich. 3,3’ - Dioctadecyloxacarbocyanine perchlorate (DiO) was purchased from Molecular Probes."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Liposome pull - down assay",
      "Material used": {
        "Material Source": "Recombinant proteins and liposomes",
        "Material Name": "Recombinant GST - fusion protein, glutathione - agarose beads, fluorescence - labeled liposomes",
        "Description": "Recombinant GST - fusion protein (37.5 pmol) was bound to glutathione - agarose beads (30 μl). The beads were then mixed with 100 μl diluted liposomes (75 μM lipid)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Mutation E46K increased the binding of a - synuclein to type A liposomes by 88% and to type B liposomes by 56%. Mutation A30P reduced the binding of a - synuclein to type A liposomes by 95% and to type B liposomes by 53%, whereas mutation A53T led to a non - significant 9 - 12% reduction in the binding of a - synuclein to both liposome types."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The results are presented as means ± S.E.M. of the measurements obtained from three independent protein preparations"
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each protein preparation was run in duplicate"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Filament assembly",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "Untagged a - synuclein proteins",
        "Description": "Untagged a - synuclein proteins were used at 400 μM in 30 mM 3 - [N - Morpholino]propanesulfonic acid (Mops), pH 7.2, containing 0.02% sodium azide and 20 μM thioflavin T."
      },
      "Readout type": "Quantitative and semi - quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "E46K a - synuclein showed a faster rate of assembly and a 2.5 - fold greater total assembly than the wild - type protein at 98 h. The A53T mutant behaved in a similar way to E46K a - synuclein. The rate of assembly of the A30P mutant was slower than for wild - type a - synuclein, but the amount of assembly was similar to that of the E46K and A53T mutants at 98 h. Filaments formed from E46K a - synuclein often had a twisted morphology with a cross - over spacing of 43 nm."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The results are presented as means ± S.E.M. of the measurements obtained from three independent protein preparations"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}